ENXTBR:ONTEX
ENXTBR:ONTEXPersonal Products

Ontex Group (ENXTBR:ONTEX) Is Down 25.3% After CEO Transition And Revenue Cut News – Has The Bull Case Changed?

Ontex Group has announced that Europe Division President Laurent Nielly will succeed Gustavo Calvo Paz as CEO after the May 5, 2026 shareholders’ meeting, while also cutting its 2025 revenue outlook and warning of a high single digit like-for-like revenue drop in the fourth quarter versus last year. At the same time, Ontex is tripling baby pants production capacity in North America to support retailer-brand growth in a segment where U.S. consumers are increasingly opting for affordable,...
ENXTBR:ARGX
ENXTBR:ARGXBiotechs

argenx (ENXTBR:ARGX): Assessing Valuation Ahead of Antibody Engineering & Therapeutics Conference Updates

argenx (ENXTBR:ARGX) heads into the Antibody Engineering and Therapeutics conference in San Diego, with investors watching closely for fresh signals on its antibody pipeline and what that might mean for the stock. See our latest analysis for argenx. The conference buzz comes after a strong run for argenx, with the share price now at $753.2 and a roughly 18% 3 month share price return contributing to a 106% three year total shareholder return. This suggests momentum is still very much on its...
ENXTBR:DEME
ENXTBR:DEMEConstruction

How New BC-Wind Contracts Could Shape DEME Group’s (ENXTBR:DEME) Offshore Wind Investment Narrative

DEME Group has recently secured three contracts to install monopile foundations, inter-array cables and an export cable for the BC-Wind offshore wind farm in Poland, reinforcing its role in the country’s renewable energy rollout. These wins further deepen DEME’s exposure to offshore wind infrastructure, expanding its project pipeline in a market focused on accelerating its energy transition. We’ll now examine how securing BC-Wind’s foundation and cable installation work could influence...
ENXTBR:SOLB
ENXTBR:SOLBChemicals

Solvay (ENXTBR:SOLB): Assessing Valuation After a 12% Year-to-Date Share Price Decline

Solvay (ENXTBR:SOLB) has drifted lower this year, even as its long term track record and steady cash generation remain intact. This may create an interesting entry point for investors who can tolerate near term volatility. See our latest analysis for Solvay. Over the past year, Solvay has seen its share price drift lower, with a year to date share price return of minus 12.08 percent. Even so, its five year total shareholder return of 70.32 percent still points to a solid long term wealth...
ENXTBR:KBCA
ENXTBR:KBCABanks

Is It Too Late To Consider KBC Ancora After Its 52% Share Price Surge?

Wondering if KBC Ancora is still a smart buy after its big run up, or if you are turning up late to the party? This breakdown will help you decide whether the current price really makes sense. The share price has climbed an impressive 51.9% over the last year and 169.6% over five years, even after a recent 2.1% slip over the past week and a 2.9% gain in the last month. Much of this move has been driven by shifting sentiment toward European financials and holding companies that give leveraged...
ENXTBR:ENRGY
ENXTBR:ENRGYElectrical

European Growth Stocks With High Insider Stakes

As European markets show resilience with the STOXX Europe 600 Index rising by 2.35%, investors are keenly observing inflation trends and fiscal policies that could shape economic stability in the region. In this context, growth companies with high insider ownership can be particularly appealing, as they often signal strong confidence from those closest to the business and may offer potential for robust performance amid evolving market conditions.
ENXTBR:FLOB
ENXTBR:FLOBFood

European Growth Stocks With Strong Insider Ownership

As European markets navigate the challenges posed by inflated AI stock valuations and shifting interest rate expectations, investors are increasingly focused on identifying growth opportunities that can withstand such volatility. In this context, companies with high insider ownership often signal strong alignment between management and shareholder interests, making them potentially attractive in today's uncertain economic landscape.
ENXTBR:AZE
ENXTBR:AZETrade Distributors

Assessing Azelis Group After a 51% Slide in 2025: Is Opportunity Emerging?

Wondering if Azelis Group might be an overlooked value pick or if caution is justified? You are not alone. There is a lot to unpack on this stock right now. The share price has taken a notable dive recently, falling 4.3% in the last week and tumbling over 14% in the past month. This brings the year-to-date performance down by a steep 51.3%. These sharp moves are drawing attention, especially since the chemical distributor sector has faced ongoing volatility amidst shifting market conditions...
ENXTBR:AGFB
ENXTBR:AGFBHealthcare Services

Agfa-Gevaert (ENXTBR:AGFB) Valuation in Focus After Q3 Earnings Reveal Wider Quarterly Losses and Sales Dip

Agfa-Gevaert (ENXTBR:AGFB) just released its third quarter and nine-month 2025 earnings results. The report shows that sales have dipped and net losses have widened this quarter compared to the same period last year. See our latest analysis for Agfa-Gevaert. Agfa-Gevaert’s latest trading has been turbulent, with the share price dropping sharply by 20% over the past week and now sitting at $0.625. Looking at the bigger picture, momentum is clearly weak, as the 1-year total shareholder return...
ENXTBR:AGFB
ENXTBR:AGFBHealthcare Services

Agfa-Gevaert (ENXTBR:AGFB) Quarterly Losses: What Do They Reveal About Management’s Turnaround Strategy?

Agfa-Gevaert NV recently reported its third quarter 2025 earnings, revealing sales of €257 million and a net loss of €19 million, both down compared to the same period last year. Although the company's nine-month net loss improved versus the previous year, the quarterly results point to continued operational headwinds affecting Agfa-Gevaert's performance. We'll explore how the combination of declining quarterly sales and a widening net loss is shaping Agfa-Gevaert's investment narrative. AI...